Background

Citations

[1] Kovesdy C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. Kidney international supplements12(1), 7–11. https://doi.org/10.1016/j.kisu.2021.11.003

[2] Ammirati A. L. (2020). Chronic Kidney Disease. Revista da Associacao Medica Brasileira (1992)66Suppl 1(Suppl 1), s03–s09. https://doi.org/10.1590/1806-9282.66.S1.3

[3] Ginsberg, J. M., Chang, B. S., Matarese, R. A., & Garella, S. (1983). Use of single voided urine samples to estimate quantitative proteinuria. The New England journal of medicine309(25), 1543–1546. https://doi.org/10.1056/NEJM198312223092503

[4] Levin, A., & Stevens, P. E. (2014). Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney international85(1), 49–61. https://doi.org/10.1038/ki.2013.444

[5] Gillespie K. M. (2006). Type 1 diabetes: pathogenesis and prevention. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne175(2), 165–170. https://doi.org/10.1503/cmaj.060244

[6] Bullard KM, Cowie CC, Lessem SE, et al. Prevalence of Diagnosed Diabetes in Adults by Diabetes Type — United States, 2016. MMWR Morb Mortal Wkly Rep 2018;67:359–361. DOI: http://dx.doi.org/10.15585/mmwr.mm6712a2.

[7] Lucier J, Weinstock RS. Type 1 Diabetes. [Updated 2023 Mar 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507713/

[8]Gomez, A. M., & Umpierrez, G. E. (2014). Continuous glucose monitoring in insulin-treated patients in non-ICU settings. Journal of diabetes science and technology8(5), 930–936. https://doi.org/10.1177/1932296814546025